v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (37,590,421) $ (251,658)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Changes in allowances - accounts receivable (2,694,263) (262,764)
Changes in allowances - advances to suppliers 31,692,011 0
Changes in allowances - other current assets 67,260 0
Long-term investment impairment loss 7,044,116 0
Depreciation 36,854 8,863
Amortization of operating lease right-of-use assets 2,275,501 1,785,055
Loss on short-term investment 0 431,180
Loss from disposal of subsidiaries 0 (250,331)
Amortization of debt issuance costs 0 177,014
Interest expenses for promissory note redemption 89,631 184,176
Amortization of biological assets 0 105,645
Changes in operating assets and liabilities:    
Accounts receivable, net (3,935,498) (8,418,637)
Advances to suppliers, net (22,845,676) 16,848,563
Note receivable 23,850,200 0
Inventories, net 1,569,350 3,687,897
Other current assets (1,412,292) 550,819
Other non-current assets - security deposits 995,640 0
Accounts payable 453,724 964,027
Operating lease liabilities (2,275,500) (1,788,947)
Other current liabilities 1,399,058 799,065
Net cash (used in) provided by operating activities (1,280,305) 14,569,967
Cash flows from investing activities    
Purchase of property and equipment (418,763) (16,666)
Proceeds from disposal of subsidiaries, net of cash 0 (19,243)
Purchase of long-term investments 0 (15,000,000)
Loan to a third party (3,842,464) 0
Repayment of loan to a third party 1,244,431 0
Net cash used in investing activities (3,016,796) (15,035,909)
Cash flows from financing activities    
Repayment of promissory notes 0 (1,000,000)
Borrowings from a third-party loan 0 1,679,900
Repayment of a third-party loan (1,809,780) (471,472)
Proceeds from issuance of ordinary shares for warrants exercised 2,000,000 781,980
Due from a related party (35,000) (115,200)
Proceeds from advances from related parties 3,586,008 0
Net cash provided by financing activities 3,741,228 875,208
Effect of exchange rate changes on cash 1,027 (5,452)
Net (decrease) increase in cash (554,846) 403,814
Cash and restricted cash, beginning of period 804,098 486,522
Cash and restricted cash, end of period 249,252 890,336
Representing:    
Cash, end of period 248,578 890,336
Restricted cash, end of period 674 0
Total cash and restricted cash, end of period 249,252 890,336
Supplemental disclosure information:    
Income taxes paid 0 0
Interest paid 73,156 126,226
Non-cash financing activities    
Acquisition of long-term investment through issuance of note receivable 0 35,000,000
Issuance of ordinary shares for promissory notes redemption 0 338,009
Accrued interest in promissory notes $ 0 $ 112,814